http://pubs.acs.org/doi/abs/10.1021/nn405077y
Abstract
Neurogenesis,
a process of generation of new neurons, is reported to be reduced in
several neurodegenerative disorders including Alzheimer’s disease (AD).
Induction of neurogenesis by targeting endogenous neural stem cells
(NSC) could be a promising therapeutic approach to such diseases by
influencing the brain self regenerative capacity. Curcumin, a
neuroprotective agent has poor brain bio-availability. Herein, we report
that curcumin-encapsulated PLGA nanoparticles (Cur-PLGA-NPs) potently
induce NSC proliferation and neuronal differentiation in vitro and in
the hippocampus and subventricular zone of adult rats, as compared to
uncoated bulk curcumin. Cur-PLGA-NPs induce neurogenesis by
internalization into the hippocampal NSC. Cur-PLGA-NPs significantly
increase expression of genes involved in cell proliferation (reelin,
nestin and Pax6) and neuronal differentiation (neurogenin, neuroD1,
neuregulin, neuroligin and Stat3). Curcumin nanoparticles increase
neuronal differentiation by activating the Wnt/β-catenin pathway,
involved in regulation of neurogenesis.
These nanoparticles caused
enhanced nuclear translocation of β-catenin, decreased GSK-3β levels,
and increased promoter activity of the TCF/LEF and cyclin-D1.
Pharmacological and siRNA mediated genetic inhibition of the Wnt pathway
blocked neurogenesis stimulating effects of curcumin. These
nanoparticles reverse learning and memory impairments in an amyloid beta
induced rat model of AD like phenotypes, by inducing neurogenesis. In
silico molecular docking studies suggest that curcumin interacts with
Wif-1, Dkk and GSK-3β. These results suggest that curcumin nanoparticles
induce adult neurogenesis through activation of the canonical
Wnt/β-catenin pathway, and may offer a therapeutic approach to treating
neurodegenerative diseases such as AD, by enhancing a brain self repair
mechanism.
No comments:
Post a Comment